solution for injection or concentrate for solution for infusion.
Sponsors
Amag Pharmaceuticals Inc.
Conditions
Iron Deficiency Anemia (IDA)Iron Deficiency Anemia (IDA) in Pediatric Subjects with Chronic Kidney Disease (CKD)
Phase 3
A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
RecruitingCTIS2024-516264-28-00
Start: 2019-09-03Target: 51Updated: 2024-09-13
A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatrics Subjects with Chronic Kidney Disease (CKD)
Active, not recruitingCTIS2024-516263-92-00
Start: 2018-06-25Target: 25Updated: 2025-06-30